Nanoform Finland Oyj: Nanoform Q2 2026 - Positive feedback from scientific advice meeting in the UK, significantly improved cash flow and discussions with CDMOs on sterile GMP for our Biologics technology initiated

Nanoform Finland Plc | Company Release | August 20, 2026 at 08:10:00 EEST Nanoenzalutamide project continues with the communicated multitrack strategy supported by all partners. After a positive sc...